A 22-year-old with 2 years of recurrent nausea and vomiting was diagnosed with CHS after extensive inconclusive testing; symptoms improved with cessation but returned on relapse.
Emergency physicians, gastroenterologists, family doctors
2 years of unnecessary investigations before CHS was diagnosed
What the researchers found
CHS diagnosed using Rome IV criteria after 2 years of unnecessary investigations; minimum 3 months cannabis cessation required for diagnosis confirmation; symptoms recurred with relapse.
Why it matters
CHS remains underdiagnosed because many clinicians do not ask about cannabis use or know the diagnostic criteria, leading to prolonged suffering.
The numbers in context
22-year-old; daily cannabis user; 2 years of symptoms before diagnosis; minimum 3 months cessation required.
How the study worked
Case report of a 22-year-old female daily cannabis user with 2 years of cyclic nausea, vomiting, and abdominal pain; diagnosed after applying Rome IV criteria.
What this study cannot tell us
Single case report; cannot generalize; 3-month cessation timeframe from expert consensus rather than rigorous trials.
How to read the evidence
Single case report provides clinical illustration but cannot establish prevalence or treatment efficacy.
When this study was published
Published 2025
The bigger picture
As cannabis use increases post-legalization, CHS prevalence is rising, making clinical awareness increasingly important.
Questions still open
- How many emergency visits for cyclic vomiting are undiagnosed CHS? Would systematic cannabis screening reduce diagnostic delay? Is 3 months sufficient for all patients?
Common questions
What is cannabinoid hyperemesis syndrome?
Why is CHS hard to diagnose?
Read the original research
Proper counseling for diagnosis and management of cannabinoid hyperemesis syndrome: a case report.
Family practice, 42(2)
Citation
Cholette-Tétrault, Samuel; Grad, Roland. (2025). Proper counseling for diagnosis and management of cannabinoid hyperemesis syndrome: a case report.. Family practice, 42(2). https://doi.org/10.1093/fampra/cmae067